Sveinn Sölvason, President and CEO, comments: “We delivered our highest ever quarterly sales in Q2 2024 with sales amounting to USD 217 million. Organic growth stood at 6% for Q2 with continued strong momentum in EMEA, driven by a strong performance in Prosthetics & Neuro Orthotics and Patient Care. Our profitability was strong for the quarter with an EBITDA margin of 22%."

Embla will host a conference call on July 23, 2024, at 09:00 CET / 7:00 GMT / 3:00 EST.

A webcast can be followed by clicking the link below:
https://edge.media-server.com/mmc/p/uwq4viec

To actively participate in the Q&A session of the conference call, please click on this link: https://register.vevent.com/register/BIa0b78474778d419291254a5b8d31d12c.

To view or download the investor presentation & company announcement, please visit our Reports & Presentations page.